Application | Comment | Organism |
---|---|---|
pharmacology | Plasmodium falciparum lysyl-tRNA synthetase (PfKRS) as the cellular target for cladosporin activity. Targeting parasitic aminoacyl-tRNA synthetases (aaRSs) can provide an additional component in the present multi-drug cocktail therapy against malaria | Plasmodium falciparum |
Crystallization (Comment) | Organism |
---|---|
purified enzyme PfKRS in complex with lysine and cladosporin, hanging drop vapour diffusion method, mixing of 0.001 ml of highly pure enzyme in 50 mM Tris-HCl, pH 8.0, 200 mM NaCl, 10 mM 2-mercaptoethanol, 0.5 mM cladosporin, and 2 mM L-lysine, with 0.001 ml of crstallization solution containing 0.1 M Bis-Tris, pH 6.5, 2% v/v Tascimate, pH 6.0, 20% w/v PEG 3350, 20°C, 10 days, X-ray diffraction structure determination and analysis at 2.7 A resolution, molecular homology modeling using the human enzyme structure as template | Plasmodium falciparum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
cladosporin | has the ability to mimic the natural substrate adenosine and thereby colonize the PfKRS active site, binding structure analysis, overview. Plasmodium falciparum lysyl-tRNA synthetase (PfKRS) as the cellular target for cladosporin activity. Structural basis of inhibition by cladosporin, overview. The isocoumarin moiety of cladosporin stacks between Ph342 and Arg559 in PfKRS. In addition, His338 provides edge-toface interaction with hydroxybenzene ring of isocoumarin moiety. The THP ring points towards L-Lys binding pocket and its methyl group faces Ser344 | Plasmodium falciparum |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Plasmodium falciparum | Q8IDJ8 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
Lysyl-tRNA synthetase | - |
Plasmodium falciparum |
PF3D7_1350100 | - |
Plasmodium falciparum |
PfKRS | - |
Plasmodium falciparum |